|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer显示文摘 | Kyoichi Kaira Tateaki Naito Toshiaki Takahashi Eriko Ayabe Rai Shimoyama Rieko Kaira Akira Ono Satoshi Igawa Takehito Shukuya Haruyasu Murakami Asuka Tsuya Yukiko Nakamura Masahiro Endo Nobuyuki Yamamoto | 2009 | Lung Cancer2009，，1： | 1 |
| 2 | Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases显示文摘 | Takaaki Tokito Takehito Shukuya Hiroaki Akamatsu Tetsuhiko Taira Akira Ono Hirotsugu Kenmotsu Tateaki Naito Haruyasu Murakami Toshiaki Takahashi Masahiro Endo Nobuyuki Yamamoto | 2013 | Cancer Chemotherapy and Pharmacology2013，，6： | 1 |
| 3 | Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver flbrogenesis-related markers 显示文摘 | Tateaki Y Ogawa T Kawada N | 2004 | Histochem Cell Biol2004，122，1： | 1 |
| 4 | Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure显示文摘 | Takehito Shukuya Toshiaki Takahashi Tateaki Naito Rieko Kaira Akira Ono Yukiko Nakamura Asuka Tsuya Hirotsugu Kenmotsu Haruyasu Murakami Hideyuki Harada Koichi Mitsuya Masahiro Endo Yoko Nakasu Kazuhisa Takahashi Nobuyuki Yamamoto | 2011 | Lung Cancer2011，，3： | 1 |
| 5 | Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases显示文摘 | Takafumi Suda Yusuke Kaida Yutaro Nakamura Noriyuki Enomoto Tomoyuki Fujisawa Shiro Imokawa Hideo Hashizume Tateaki Naito Dai Hashimoto Yasuo Takehara Naoki Inui Hirotoshi Nakamura Thomas V. Colby Kingo Chida | 2009 | Respiratory Medicine2009，，6： | 1 |
| 6 | Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer显示文摘 | Akira Ono Tateaki Naito Haruyasu Murakami Toshiaki Takahashi Yukiko Nakamura Asuka Tsuya Kyoichi Kaira Satoshi Igawa Takehiro Shukuya Akihiro Tamiya Rieko Kaira Masahiro Endo Nobuyuki Yamamoto | 2010 | International Journal of Clinical Oncology2010，，2： | 1 |
| 7 | Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer显示文摘 | Akira Ono Tateaki Naito Ichiro Ito Reiko Watanabe Takehito Shukuya Hirotsugu Kenmotsu Asuka Tsuya Yukiko Nakamura Haruyasu Murakami Kyoichi Kaira Toshiaki Takahashi Toru Kameya Takashi Nakajima Masahiro Endo Nobuyuki Yamamoto | 2011 | Lung Cancer2011，，3： | 1 |
| 8 | Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer显示文摘 | Tateaki Naito Fumihiro Tanaka Akira Ono Kazue Yoneda Toshiaki Takahashi Haruyasu Murakami Yukiko Nakamura Asuka Tsuya Hirotsugu Kenmotsu Takehito Shukuya Kyoichi Kaira Yasuhiro Koh Masahiro Endo Seiki Hasegawa Nobuyuki Yamamoto | 2012 | Journal of Thoracic Oncology2012，，3： | 1 |
| 9 | Evaluation of S-1 as third-or further-line chemotherapy in advanced non-small-cell lung cancer显示文摘 | Akira O Tateaki N Haruyasu M | | 0，，02： | 1 |
| 10 | 显示文摘 | Hiroyukin N Kazuo O Tateaki O | 1986 | The Chemical Society of Japan1986，，8： | 1 |
| 11 | Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more显示文摘 | Akihiro Tamiya Tateaki Naito Akira Ono Eriko Ayabe Asuka Tsuya Yukiko Nakamura Kyoichi Kaira Haruyasu Murakami Toshiaki Takahashi Masahiro Endo Nobuyuki Yamamoto | 2010 | Lung Cancer2010，，2： | 1 |
| 12 | Synthesis and stereochemistry of carnosadine, a new cyclopropyl amino acid from red alga Grateloupia carnosa显示文摘 | Wakamiya Tateaki Oda | 1986 | Tetrah Lett1986，27，19： | 1 |
| 13 | Typing of hepatic nonparenehymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers 显示文摘 | Tateaki Y Ogawa T Kawada N | 2004 | Histochem Cell Biol2004，122，1： | 1 |
| 14 | Isolation of 1-Amino-2-(guanidinomethyl) cyclopropane-l-carboxylic acid from red alga Grateloupia lividu 显示文摘 | Shiba T Wakamya Tateaki | 1987 | Nippon Suisan Gakkaishi1987，53，3： | 1 |
| 15 | Long-term survival of more than 3 years among patients with advanced non-small cell lung cancer treated with chemotherapy显示文摘AIM: To evaluate the prognostic factors of long-term survival of more than 3 years in patients with advanced non-small cell lung cancer(NSCLC). METHODS: We retrospectively analyzed the records of 474 patients with advanced ⅢB/Ⅳ NSCLC who received chemotherapy as initial treatment between September 2002 and March 2007.RESULTS: The median survival time(MST) was 12.5 mo and the 3 year and 5 year survival rates were 14.6% and 5.3%, respectively. Long-term survival of more than 3 and 5 years was observed in 65 and 16 patients, respectively. The MST for the 65 patients was61.5 mo(range, 60.1-81.0 mo). In the 474 patients, a good performance status(PS), female sex, non-smoking status and adenocarcinoma histology were significantly associated with a favorable outcome. Furthermore, female sex, a good PS, non-smoking status and adenocarcinoma histology were significantly correlated with longterm survival of more than 3 years and most of these patients(89.2%, 58/65) received epidermal growth factor receptor-tyrosine kinase inhibitors as any line treatment. Survival analysis of long-term survivors showed that a PS of 0 was an independent prognostic factor for predicting favorable outcomes. CONCLUSION: Our results suggest that a good PS and adenocarcinoma histology play an important role in long-term survival of more than 3 years. A PS of 0 was an independent prognostic factor for predicting favorable outcomes in patients with advanced NSCLC who survived for more than 3 years. | Rieko Kaira Kyoichi Kaira Takehito Shukuya Hirotsugu Kenmotsu Akira Ono Haruyasu Murakami Asuka Tsuya Yukiko Nakamura Tateaki Naito Masahiro Endo Nobuyuki Yamamoto Toshiaki Takahashi | 2013 | World Journal of Respirology2013，3，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员